2022 - The year of recovery for Medipharm is almost here!Tax loss selling appears to be over and shorts will start to cover on regular news updates from the corporation all making for a very interesting 2022 for Medipharm shareholders.
Much slower than what I originally thought, but considering the past couple years, I guess everything is off the table until its not!